Cargando…
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
Male breast cancer represents about 1% of all breast cancer diagnoses and, although there are some similarities between male and female breast cancer, the paucity of data available on male breast cancer makes it difficult to establish targeted therapies. To date, most male breast cancers (MBCs) are...
Autores principales: | Kim, Hyunsoo, Wisniewska, Kamila, Regner, Matthew J., Thennavan, Aatish, Spanheimer, Philip M., Franco, Hector L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487538/ https://www.ncbi.nlm.nih.gov/pubmed/37685859 http://dx.doi.org/10.3390/ijms241713053 |
Ejemplares similares
-
Odontogenic keratocyst: Analysis of recurrence by AgNOR, p53 and MDM2 profiling
por: Chandrashekar, Chetana, et al.
Publicado: (2020) -
Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023) -
Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023) -
Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer
por: Lewis, Michael W., et al.
Publicado: (2022) -
Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study
por: Thennavan, Aatish, et al.
Publicado: (2022)